SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2019
Anchiano Therapeutics Ltd.
(Translation of registrant’s name into English)
1/3 High-Tech Village, Givat Ram, P.O. Box 39264
Jerusalem, 9139102 Israel
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x | Form 40-F ¨ |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
On August 5, 2019, Anchiano Therapeutics Ltd. announced its second quarter 2019 financial results. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Exhibit No. | Description of Exhibit |
99.1 | Press Release dated August 5, 2019 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Anchiano Therapeutics Ltd. | |||
By: | /s/ Dr. Frank G. Haluska | ||
Dr. Frank G. Haluska | |||
Chief Executive Officer | |||
Dated August 5, 2019 |
Exhibit 99.1
FOR IMMEDIATE RELEASE
Anchiano Therapeutics Reports Second Quarter 2019 Financial Results
CAMBRIDGE, Mass., Aug. 5, 2019 - Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, today reported financial results for its second quarter and six months ended June 30, 2019.
Key Developments and Recent Highlights
· | Appointed Salar Roshan as the Head of Business Development to focus on leading Anchiano’s strategic initiatives. |
· | Delisted the company’s ordinary shares from trading on the Tel Aviv Stock Exchange (TASE). Anchiano’s American Depositary Shares, each representing five of its ordinary shares, continue to be traded on the Nasdaq under the ticker “ANCN.” |
Second Quarter 2019 Financial Results:
On June 30, 2019, Anchiano had total cash and cash equivalents of approximately $27 million, compared to approximately $7.5 million on December 31, 2018.
Research and development expenses for the second quarter of 2019 were approximately $2.6 million, compared to approximately $1.9 million for the second quarter of 2018. This increase was mainly due to an increase in clinical trial expenses and an increase in clinical manpower expenses.
General and administrative expenses for the second quarter of 2019 were approximately $1.9 million, compared to approximately $2.3 million for the second quarter of 2018. This decrease was mainly due to a decrease in share-based payment and issuance expenses, offset by increases in professional, consulting, rental, insurance and manpower expenses.
Financing income (expenses), net, for the second quarter of 2019 were approximately $2.8 million, compared to approximately $(0.8) million for the second quarter of 2018. This change was mainly due to changes in the fair value of derivative financial instruments.
Net loss for the second quarter of 2019 was approximately $1.8 million, or $0.05 per share, compared to approximately $5.3 million, or $0.55 per share in the second quarter of 2018.
Six Months Ended June 30, 2019 Financial Results:
Research and development expenses for the six months ended June 30, 2019 were approximately $6.7 million, compared to approximately $4.4 million for the same period in 2018. This increase was mainly due to an increase in clinical trial expenses, manufacturing expenses and an increase in clinical manpower expenses.
General and administrative expenses for the six months ended June 30, 2019 were approximately $3.1 million, similar to expenses of approximately $3.2 million for the same period in 2018. The decrease was mainly due to a decrease in share-based payment and issuance expenses, offset by increases in professional, consulting, rental, insurance and manpower expenses.
Financing expenses, net, in the six months ended June 30, 2019 were approximately $10.1 million, compared to approximately $0.9 million for the same period in 2018. This change was mainly due to changes in the fair value of derivative financial instruments.
Net loss for the six months ended June 30, 2019 was approximately $20.3 million, or $0.64 per share, compared to approximately $8.8 million, or $0.92 per share for the same period in 2018.
About Anchiano
Anchiano is a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer, with offices in Cambridge, MA, and Jerusalem, Israel. Anchiano’s most advanced product candidate, inodiftagene, is in development as a treatment for non-muscle-invasive bladder cancer. For more information on Anchiano, please visit www.anchiano.com.
Forward-Looking Statements
This press release contains “forward-looking statements” that are subject to risks and uncertainties. Words such as “believes,” “intends,” “expects,” “projects,” “anticipates” and “future” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions, many of which are beyond the control of Anchiano, including, without limitation, the risk factors and other matters set forth in its filings with the Securities and Exchange Commission, including its Annual Report on Form 20-F for the year ended December 31, 2018. Anchiano undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.
Company Contact:
Frank Haluska, M.D., Ph.D.
President and Chief Executive Officer
info@anchiano.com
Investor Contact:
Ashley R. Robinson
Managing Director
LifeSci Advisors, LLC
617-535-7742
arr@lifesciadvisors.com
RESULTS OF OPERATIONS (unaudited)
U.S. dollars in thousands
Six Months Ended June 30, | Three Months Ended June 30, | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
Operating expenses | ||||||||||||||||
Research and development expenses | 6,730 | 4,350 | 2,589 | 1,875 | ||||||||||||
General and administrative expenses | 3,147 | 3,213 | 1,854 | 2,287 | ||||||||||||
Operating loss | 9,877 | 7,563 | 4,443 | 4,162 | ||||||||||||
Financing expenses (income), net | 10,101 | 881 | (2,772 | ) | 806 | |||||||||||
Loss before income tax | 19,978 | 8,444 | 1,671 | 4,968 | ||||||||||||
Income tax | 279 | 393 | 139 | 330 | ||||||||||||
Net loss for the period | 20,257 | 8,837 | 1,810 | 5,298 |
STATEMENTS OF FINANCIAL POSITION (unaudited)
U.S. dollars in thousands
June 30, 2019 | December 31, 2018 | |||||||
Assets | ||||||||
Current Assets | 27,895 | 10,920 | ||||||
Non-Current Assets | 3,161 | 1,654 | ||||||
Total Assets | 31,056 | 12,574 | ||||||
Liabilities | ||||||||
Current Liabilities | 3,239 | 10,036 | ||||||
Non-Current Liabilities | 2,934 | 3,628 | ||||||
Total Liabilities | 6,173 | 13,664 | ||||||
Equity | ||||||||
Total equity (deficiency) | 24,883 | (1,090 | ) | |||||
Total Liabilities and Equity | 31,056 | 12,574 |
CASH FLOWS (unaudited)
U.S. dollars in thousands
Six Months Ended June 30, | ||||||||
2019 | 2018 | |||||||
Net cash used in operating activities | (6,781 | ) | (4,596 | ) | ||||
Net cash used in investing activities | (91 | ) | (158 | ) | ||||
Net cash provided by financing activities | 26,377 | 22,901 | ||||||
Effect of exchange rate differences on cash and cash equivalents | (12 | ) | (69 | ) | ||||
Net increase in cash and cash equivalents | 19,493 | 18,078 |
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end